|
|
See what our clients have to say about working with DrFirst.
>more
|
Are you searching for the right strategy for e-prescribing?
Right now, many health systems are taking advantage of recent changes to federal regulations and are connecting physicians and hospitals nationwide through e-prescribing. The federal Stark law, which limits the scope of hospital-physician relationships, has been relaxed to enable hospitals to assist non-employed physicians in adopting healthcare information technologies, including e-prescribing, to enhance patient safety and quality-of-care.
By offering Rcopia e-prescribing to affiliated and non-affiliated physicians, by selecting DrFirst partner EMRs, and by implementing RcopiaAC medication reconciliation in the hospital, health systems can provide a seamless connection to critical patient information along the entire continuum-of-care. DrFirst allows health systems to not only deliver proven benefits in the areas of reduced drug spending, increased patient safety and reduced medical costs but also offer truly integrated patient care.
DrFirst provides unique application and connectivity solutions for ambulatory and acute care environments with a focus on “connecting communities” through interoperability and secure data sharing. Entire communities of physicians, patients and healthcare stakeholders can receive benefits from e-prescribing while closing continuity-of-care gaps.
In this case study, you will see how Henry Ford Health System was able to achieve the following ROI when partnering with DrFirst for their e-prescribing initiative:
- Initial capital investment of $1.6 million
- Estimated savings through 2009 will average $4 million per year
- Based on the 2005 and 2006 realized improvement in generic use rate, the five year Return On Investment is now estimated to be over $14M
- Key sources of cost reduction benefit are:
- GUR Improvement – totaling $1.5 million for 2005 & 2006 and estimated at $3 million per year for 2007-2009
- Administrative savings – totaling $700,000 for 2005 & 2006 and estimated at $560,000 per year for 2007-2009
- Estimated impact of reduced adverse drug events (ADEs) – totaling $540,000 for 2005 and 2006 and $540,000 per year for 2007-2009
- Over 80,000 prescriptions changed or cancelled due to formulary warnings
- Improved generic use rate overall from 56.7% to 70.5% (24% improvement)
- Over 200,000 prescriptions changed or cancelled due to drug to drug interaction warnings
- Over 15,000 prescriptions changed or cancelled due to drug/allergy warnings
Want to learn more about the overall solutions DrFirst offers and how we can empower your greater HIT strategies and work with you to create flexible business models that drive desired results while fitting into your budget and operational requirements? Fill out the contact form to the right and a representative will contact your shortly.
^back to top
|
Interested in learning more? Fill out the form below, and a representative will contact you shortly. Or give us a call at 888.271.9898.
|
|
